Maher Masoud

CIK: 0001874571

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MXCT

MAXCYTE, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

MXCT
MAXCYTE, INC.
Aug 13, 2025
Purchase(P)
Direct
75K shares at avg. $1.37$103K
MXCT
MAXCYTE, INC.
Mar 14, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
347.5K shares-

		Type	Shares	Price		Ownership
Aug 13, 2025	MXCT MAXCYTE, INC.	Purchase(P)	75,000	$1.37	$102,915	Direct
Mar 14, 2025	MXCT MAXCYTE, INC.	Award(A) Employee Stock Option (right to buy)	347,500	-	-	Direct

1-2 of 2 transactions

About Masoud Maher

Masoud Maher (SEC CIK 0001874571) files insider reports with the SEC as President and CEO of MAXCYTE, INC. (MXCT).

Signal8 holds 2 ownership filings by Masoud Maher, all Form 4s, filed between Mar 18, 2025 and Aug 13, 2025. Those filings report 2 transactions, from Mar 14, 2025 to Aug 13, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Masoud Maher's filings is in ROCKVILLE, MD.

Recent filings by Masoud Maher

Aug 13, 2025: Open-market purchase of MXCT shares (Form 4, code P).
Mar 14, 2025: Grant or award of MXCT derivative securities (Form 4, code A).

Other insiders filing for MAXCYTE, INC. (MXCT)

Johnston John Joseph, Director
Hemrajani Rekha, Director
Erck Stanley C, Director
DOUGLAS RICHARD, Director
Collins Cynthia, Director
Brooke William W, Director

How to read Form 4 transaction codes